Animas, a Johnson & Johnson company, has received the FDA clearance for its OneTouch Ping glucose management system.
Subscribe to our email newsletter
According to the company, OneTouch Ping is the first full-feature insulin pump that wirelessly communicates with a blood glucose meter-remote. Using the OneTouch Ping meter-remote, a person can calculate insulin doses and opt to wirelessly instruct the pump to deliver them without touching the pump at all, giving patients more freedom and flexibility in using their insulin pump, the company said.
OneTouch Ping also marks the first integrated product from two companies within the diabetes care group of Johnson & Johnson – Animas, makers of insulin pumps, and LifeScan, makers of the OneTouch brand of glucose meters and OneTouch Ultra test strips.
Juan Frias, chief medical officer and vice president of medical affairs of Animas, said: “People using OneTouch Ping will no longer have to access their pump to deliver a bolus, ultimately making life with diabetes a little easier.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.